Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Suvorexant for Sleep and Opioid Abstinence in OUD
NCT04262193Phase 2Terminated
- Sponsor
- Wayne State University
- Start
- Feb 2021
- Primary completion
- Jul 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of suvorexant in opioid use disorder (OUD), sponsored by Wayne State University. Started Feb 2021; status: terminated.
02
Drugs
suvorexant
03
Conditions
opioid use disorder (OUD)
Beyond the preview
Go deeper on NCT04262193.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04262193.